City of Hope at Long Beach Elm — Long Beach, California

Public research footprint of City of Hope at Long Beach Elm, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6… · Anatomic Stage III Breast Cancer AJCC v8 · Recurrent Lung Non-Small Cell Carcinoma · Endometrial Carcinoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at City of Hope at Long Beach Elm?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.